The investment seeks long-term growth of capital... Show more
The average fundamental analysis ratings, where 1 is best and 100 is worst, are as follows
Category LargeValue
| 1 Day | |||
|---|---|---|---|
| ETFs / NAME | Price $ | Chg $ | Chg % |
| BBC | 42.20 | 0.28 | +0.67% |
| Virtus LifeSci Biotech Clinical Trls ETF | |||
| XTRE | 49.61 | 0.01 | +0.01% |
| BondBloxx Bloomberg ThreeYrTrgDurUSTrETF | |||
| LFSC | 36.32 | N/A | N/A |
| F/m Emerald Life Sciences Innovation ETF | |||
| DDFS | 21.30 | -0.05 | -0.21% |
| Innovator Eq Dual Drctnl 15 Buf ETF -Sep | |||
| APIE | 37.47 | -0.29 | -0.76% |
| ActivePassive International Equity ETF | |||
A.I.dvisor indicates that over the last year, ABVAX has been closely correlated with RMEBX. These tickers have moved in lockstep 86% of the time. This A.I.-generated data suggests there is a high statistical probability that if ABVAX jumps, then RMEBX could also see price increases.
| Ticker / NAME | Correlation To ABVAX | 1D Price Change % | ||
|---|---|---|---|---|
| ABVAX | 100% | +0.72% | ||
| RMEBX - ABVAX | 86% Closely correlated | -0.17% | ||
| RMFEX - ABVAX | 86% Closely correlated | -0.15% | ||
| RMFCX - ABVAX | 86% Closely correlated | -0.15% | ||
| VVIAX - ABVAX | 85% Closely correlated | +0.51% | ||
| VIVIX - ABVAX | 85% Closely correlated | +0.51% | ||
More | ||||